Bolt Biotherapeutics (BOLT) Misses Q3 EPS by 372c

Bolt Biotherapeutics (NASDAQ: BOLT) reported Q3 EPS of ($3.72). Revenue for the quarter came in at $2.17 million.

For earnings history and earnings-related data on Bolt Biotherapeutics (BOLT) click here.

You May Also Be Interested In

• Nscale targets up to $3B in US IPO as soon as September - Bloomberg
• Barclays sees music streaming growth narrow gap with Spotify
• Ubiquiti (UI) Tops Q4 EPS by 25c, Beats on Revenue